| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |